DS
PFE icon

DRW Securities’s Pfizer PFE Stock Holding History

DRW Securities’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-157,500
Closed -$4.02M – 1579
2025
Q3 		$4.02M Buy
+157,500
New +$3.89M 0.07% 150
2022
Q2 		– Sell
-31,500
Closed -$1.63M – 329
2022
Q1 		$1.63M Buy
+31,500
New +$1.63M 0.04% 105

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

DRW Securities's PFE Position: Q1 2026 in Review

DRW Securities reduced its Pfizer (PFE) stake by 23% in Q1 2026, selling an estimated $177K and leaving 22,683 shares worth $637K. The position accounts for 0.01% of the portfolio, ranked #504.

DRW Securities first reported a position in PFE in Q2 2013 and has held it in 17 quarters since. The position peaked at $3.71M in Q4 2015. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • DRW Securities held 22,683 shares of Pfizer worth $637K as of Q1 2026.
  • DRW Securities sold 6,632 Pfizer shares in Q1 2026, an estimated $177K.
  • Pfizer made up 0.01% of DRW Securities's portfolio in Q1 2026, its #504 holding.
  • DRW Securities first reported a position in Pfizer in Q2 2013 and has held it in 17 quarters since.
  • DRW Securities's Pfizer position peaked at $3.71M in Q4 2015.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.